Corporate Board Profile
Tech Score: 10/100
1 mention(s) identify GEORGE A. SCANGOS, PH.D. as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| AGILENT TECHNOLOGIES, INC. | 2016-02-04 | Before joining Bayer in 1987, Dr. Scangos was a Professor of Biology at Johns Hopkins University for six years. Dr. Scangos has extensive training as a scientist, significant knowledge and experience with respect to the biotechnology, healthcare and pharmaceutical industries. | Dr. Scangos has extensive scientific training and was a Professor of Biology, indicating strong technical and scientific expertise which may include programming skills. |
| Filing Date | Source Excerpt |
|---|---|
| 2016-02-04 | Before joining Bayer in 1987, Dr. Scangos was a Professor of Biology at Johns Hopkins University for six years. Dr. Scangos has extensive training as a scientist, significant knowledge and experience with respect to the biotechnology, healthcare and pharmaceutical industries. |
| 2020-02-06 | Dr. Scangos has extensive training as a scientist, significant knowledge and experience with respect to the biotechnology, healthcare and pharmaceutical industries, and a comprehensive leadership background. |
| 2022-02-03 | Dr. Scangos has extensive training as a scientist, significant knowledge and experience with respect to the biotechnology, healthcare and pharmaceutical industries. |
| 2023-02-03 | Dr. Scangos has extensive training as a scientist, significant knowledge and experience with respect to the biotechnology, healthcare and pharmaceutical industries. |
| 2025-01-31 | Dr. Scangos retired as Chief Executive Officer of Vir Biotechnology in April 2023. He has served as a director of Vir Biotechnology, Inc. since January 2017. |
| Filing Date | Source Excerpt |
|---|---|
| 2014-04-30 | Dr. Scangos is our Chief Executive Officer and has served in this position since July 2010. Dr. Scangos receives no compensation for his service on our Board of Directors. |
| 2015-04-30 | George A. Scangos, Ph.D. Age: 67 Dr. Scangos is our Chief Executive Officer and has served in this position since July 2010. Dr. Scangos receives no compensation for his service on our Board of Directors. |
| 2016-04-15 | Dr. Scangos, 67, has served as our Chief Executive Officer and one of our directors since July 2010. Prior to that, he served as the President and Chief Executive Officer of Exelixis, Inc., a drug discovery and development company, from 1996 to July 2010. From 1993 to 1996, Dr. Scangos served as President of Bayer Biotechnology, where he was responsible for research, business development, process development, manufacturing, engineering and quality assurance of Bayer's biological products. Before joining Bayer in 1987, Dr. Scangos was a Professor of Biology at Johns Hopkins University for six years, where he is still an adjunct professor. Dr. Scangos served as non-executive Chairman of Anadys Pharmaceuticals, Inc., a biopharmaceutical company, from 2005 to July 2010 and was a director of the company from 2003 to July 2010. He also served as the Chair of the California Healthcare Institute in 2010 and was a member of the board of the Global Alliance for TB Drug Development until 2010. In March 2016, Dr. Scangos was appointed Chairman of the Board of Directors of Pharmaceutical Research and Manufacturers of America (PhRMA). Dr. Scangos has extensive training as a scientist, significant knowledge and experience with respect to the biotechnology, healthcare and pharmaceutical industries, and a comprehensive leadership background resulting from service on various boards of directors and as an executive in the pharmaceutical industry. Biogen Committee Memberships: None. 2015 Director Compensation: Dr. Scangos receives no compensation for his service on our Board of Directors. |
| Filing Date | Source Excerpt |
|---|---|
| 2017-04-13 | Dr. Scangos holds a B.A. in Biology from Cornell University and a Ph.D. in Microbiology from the University of Massachusetts. Our Board has concluded that Dr. Scangos should continue to serve as a director of Exelixis as of the date of this Proxy Statement due to his prior leadership role as our President and Chief Executive Officer. |
| 2019-04-11 | Dr. Scangos holds a B.A. in Biology from Cornell University and a Ph.D. in Microbiology from the University of Massachusetts. |
Data sourced from SEC filings. Last updated: 2025-12-07